2010-03-10 12:29:04 -
Tolerx, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com
www.companiesandmarkets.com/Summary-Company-Profile/tolerx,-inc. ..
Tolerx, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Tolerx, Inc. (Tolerx) is a biopharmaceutical company, engaged in the discovery, development and commercialization of novel immunotherapies that are specifically designed to reprogram the immune system. This technology of reprogramming the immune system is used to allow long-term remission of immune-related diseases like psoriasis, lupus, diabetes and others. The company also develops therapies to treat patients with autoimmune diseases, like type I diabetes and rheumatoid arthritis. Tolerx
owns five autoimmune and two cancer/chronic viral drugs in its pipeline to serve the patients better.
And More inside the report
Recent Developments
Aug 06, 2009: Alnylam, Tekmira Participate In New Research Collaboration
May 25, 2009: Tekmira Extends Research Collaboration With Bristol-Myers Squibb
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including mergers & acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings, partnerships and licensing agreements.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick "one-stop-shop" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
